sfo /SAFIR maY 2011

9
sfo/SAFIR maY 2011 P. Vo Tan, Paris N. Jabbur, Beyrouth S. Zaluski, Perpignan P. Rozot, Marseille J. Blondel, Nice G. Grabner, Salzbourg M.H Duret, Lille D. O’Brart, Londres

description

Multicentric evaluation of a new diffractive multifocal IOL : visual performance and patients ‘ satisfaction. P. Vo Tan, ParisN. Jabbur, Beyrouth S. Zaluski, Perpignan P. Rozot, Marseille J. Blondel, Nice G. Grabner, Salzbourg M.H Duret , LilleD. O’Brart , Londres. - PowerPoint PPT Presentation

Transcript of sfo /SAFIR maY 2011

Page 1: sfo /SAFIR  maY  2011

sfo/SAFIR maY 2011

P. Vo Tan, Paris N. Jabbur, BeyrouthS. Zaluski, Perpignan P. Rozot, MarseilleJ. Blondel, Nice G. Grabner, Salzbourg M.H Duret, Lille D. O’Brart, Londres

Page 2: sfo /SAFIR  maY  2011

1-month post-op20 patients with bilateral cataract Mean age 71. 8 years (44-87)Pre-Op astigmatism ≤ 1 dptIncision size 2.2/2.4 mmIOL power= 21.1 ±1.4 dpt

Multifocal, Monobloc, Hydrophilic Acrylic Diffractive aspheric anterior surface Addition of +3.5 D (IOL plane)

SE Post-Op

Page 3: sfo /SAFIR  maY  2011

1-month post-op

Page 4: sfo /SAFIR  maY  2011

1-month post-op

Page 5: sfo /SAFIR  maY  2011

Do you wear correcting glasses?

Are you satisfied with your vision?

Youngest patient (44 years)

Page 6: sfo /SAFIR  maY  2011

Ongoing study M.H Duret, Lille

Diff Add (HumanOptics) +3,5 0 D (n=9) AT LISA (Zeiss) Add +3,75 D (n=12)Micro F (Physiol) Add +3,50 et +1,75 D (n=5)

Page 7: sfo /SAFIR  maY  2011

Mono (Aspira, n=30)

Roessler, Küchle WOC 2010MH Duret

Page 8: sfo /SAFIR  maY  2011

The new multifocal Diffractiva-aA provides excellent visual

acuity at near and far distances as well as good intermediate

distance results

The Diffractiva-aA is able to provide a high rate of spectacle

independence and minimal photic phenomena at night

The excellent visual performance of the Diffractiva-aA is

reflected by the high level of patients’ satisfaction

Page 9: sfo /SAFIR  maY  2011

The defocus curves show that, as expected, the trifocal

micro F (Physiol) provides better intermediate vision than the

two bifocal IOLs but the Diffractiva-aA outperforms the AT-

LISA (Zeiss).

The contrast sensitivity curves show that the Diffractiva-aA

outperforms the other MIOLs when patients are tested under

mesopic conditions and there is no loss of contrast sensitivity

when compared to its monofocal counterpart (Aspira)